LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) — Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value-based care, today reported financial results for the fiscal first quarter ended September 30, 2023.
BlogofInnovation.com
NEW YORK, N.Y., Sept. 12, 2024 (SEND2PRESS NEWSWIRE) — To all Pokémon GO fans, the thrill of playing should not…
Osiz Technologies, a leading innovator in healthcare AI solutions, today announced the launch of its groundbreaking AI Patient Care Service,…
Successful milestones achieved and upcoming include peer-reviewed publications, commercial agreements, and payer coverage decisionsProgressing with proven path toward standard of…
DDreg Pharma, a leading provider of healthcare and regulatory services, is proud to announce the launch of its comprehensive pharmacovigilance…
Data4Amazon, a pioneer in Amazon marketplace management and search engine optimization services, has been recognized by TopDevelopers as one of…
PicsMatic, a professional photo editing company, is excited to announce its inclusion in DesignRush’s prestigious Top California Creative Agencies List.…
